DE69920877D1 - Antimikrobiell wirksame peptide - Google Patents

Antimikrobiell wirksame peptide

Info

Publication number
DE69920877D1
DE69920877D1 DE69920877T DE69920877T DE69920877D1 DE 69920877 D1 DE69920877 D1 DE 69920877D1 DE 69920877 T DE69920877 T DE 69920877T DE 69920877 T DE69920877 T DE 69920877T DE 69920877 D1 DE69920877 D1 DE 69920877D1
Authority
DE
Germany
Prior art keywords
amino acids
antimicrobially effective
domain
effective peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69920877T
Other languages
English (en)
Other versions
DE69920877T2 (de
Inventor
Nieuw Amerongen Arie Van
Cornelis Veerman
T Hof Willem Van
Josephine Helmerhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TRIFIT HEALTHCARE GROUP B.V., OOSTKAPELLE, NL
Original Assignee
Barnaux Healthcare BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barnaux Healthcare BV filed Critical Barnaux Healthcare BV
Application granted granted Critical
Publication of DE69920877D1 publication Critical patent/DE69920877D1/de
Publication of DE69920877T2 publication Critical patent/DE69920877T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
DE69920877T 1998-01-27 1999-01-26 Antimikrobiell wirksame peptide Expired - Fee Related DE69920877T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL1008139 1998-01-27
NL1008139A NL1008139C2 (nl) 1998-01-27 1998-01-27 Antimicrobiële peptiden.
PCT/NL1999/000045 WO1999037678A2 (en) 1998-01-27 1999-01-26 Antimicrobial peptides

Publications (2)

Publication Number Publication Date
DE69920877D1 true DE69920877D1 (de) 2004-11-11
DE69920877T2 DE69920877T2 (de) 2005-02-03

Family

ID=19766423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920877T Expired - Fee Related DE69920877T2 (de) 1998-01-27 1999-01-26 Antimikrobiell wirksame peptide

Country Status (10)

Country Link
US (1) US6638531B1 (de)
EP (1) EP1051433B1 (de)
JP (1) JP2003524578A (de)
AT (1) ATE278710T1 (de)
AU (1) AU759026B2 (de)
CA (1) CA2319094C (de)
DE (1) DE69920877T2 (de)
ES (1) ES2229669T3 (de)
NL (1) NL1008139C2 (de)
WO (1) WO1999037678A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001427A1 (en) * 1998-07-02 2000-01-13 Stichting Skeletal Tissue Engineering Group Amsterdam Bone cement with antimicrobial peptides
NL1010692C2 (nl) * 1998-12-01 2000-06-06 Stichting Tech Wetenschapp Antivirale peptiden.
EP1174027A1 (de) * 2000-07-17 2002-01-23 HOM Consultancy B.V. Verwendungen antimikrobieller Peptide
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
WO2005019241A2 (en) * 2003-08-18 2005-03-03 E.I. Dupont De Nemours And Company Cationic antimicrobial peptides and compositions thereof
JP2005350424A (ja) * 2004-06-14 2005-12-22 Kyocera Chemical Corp 固形製剤および固形製剤の製造方法
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
AU2013243953A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of nuclear proteins
WO2013151666A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of biologics and proteins associated with human disease
US8963676B1 (en) * 2013-03-12 2015-02-24 XP Power Limited Configurable transformer module
US9556226B2 (en) 2013-03-15 2017-01-31 The Board Of Trustees Of The University Of Arkansas Peptides with antifungal activity and methods of using the peptides
ES2808780T3 (es) 2015-06-30 2021-03-01 Chain Antimicrobials Oy Nuevos péptidos antimicrobianos, sus variantes y usos
JP6788173B2 (ja) 2015-06-30 2020-11-25 チェイン アンチマイクロバイアルズ オイＣｈａｉｎ Ａｎｔｉｍｉｃｒｏｂｉａｌｓ Ｏｙ 新規な抗菌ペプチド、その変異体及び使用
US10457710B2 (en) 2015-06-30 2019-10-29 Chain Antimicrobials Oy Antimicrobial peptides, their variants and uses
KR20180101341A (ko) 2015-11-10 2018-09-12 비스테라, 인크. 리포폴리사카라이드에 특이적으로 결합하는 항체 분자-약물 접합체 및 그의 용도
JP6658265B2 (ja) * 2016-04-26 2020-03-04 ライオン株式会社 インビトロバイオフィルムモデルの製造方法、ならびに評価方法及び口腔用組成物を選定する方法
WO2018136626A1 (en) 2017-01-18 2018-07-26 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
WO2019139891A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
WO2019183208A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP4126064A1 (de) 2020-04-03 2023-02-08 Visterra, Inc. Antikörpermolekül-wirkstoff-konjugate und verwendungen davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5294605A (en) * 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
EP0644769A4 (de) * 1992-06-01 1995-08-09 Magainin Pharma Biologisch aktive peptide mit n-terminalen substitutionen.
US6579696B1 (en) * 1992-12-21 2003-06-17 Promega Corporation Polymyxin B conjugates
WO1996008270A2 (en) * 1994-09-13 1996-03-21 Magainin Pharmaceuticals Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds

Also Published As

Publication number Publication date
DE69920877T2 (de) 2005-02-03
AU759026B2 (en) 2003-04-03
CA2319094C (en) 2009-03-17
AU2301499A (en) 1999-08-09
NL1008139C2 (nl) 1999-07-28
WO1999037678A3 (en) 1999-10-14
EP1051433A2 (de) 2000-11-15
ATE278710T1 (de) 2004-10-15
EP1051433B1 (de) 2004-10-06
ES2229669T3 (es) 2005-04-16
CA2319094A1 (en) 1999-07-29
WO1999037678A2 (en) 1999-07-29
US6638531B1 (en) 2003-10-28
JP2003524578A (ja) 2003-08-19

Similar Documents

Publication Publication Date Title
DE69920877D1 (de) Antimikrobiell wirksame peptide
ATE241643T1 (de) Therapeutisch wirksame peptidderivate
DE60235761D1 (de) Isoform des vegfs
DE69732250D1 (de) Zyklische peptide mit breitspektrum antimikrobieller aktivität
ATE491024T1 (de) Xylanase-varianten mit veränderter sensitivität gegenüber xylanase-hemmstoffen
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
NO20001269D0 (no) Basiske salter av N-[N-(3,3-dimetylbutyl)-L-<alfa>-aspartyl]- L-fenylalanin-1-metylester
NO20001271D0 (no) Søtningssalter av N-[N-(3,3-dimetylbutyl)-L-<alfa>-aspartyl]- L-fenylalanin-1-metylester
NO20001270D0 (no) Sure salter av N-[N-(3,3-dimetylbutyl)-L-<alfa>-aspartyl]-L- fenylalanin-1-metylester
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
ES2190605T3 (es) Peptido con afinidad hacia el factor de coagulacion viii.
DE59301060D1 (de) Substituierte Aminosäureamide.
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
ATE171460T1 (de) Synthetische amphipatische peptide mit antimikrobieller wirksamkeit
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TRIFIT HEALTHCARE GROUP B.V., OOSTKAPELLE, NL

8339 Ceased/non-payment of the annual fee